DECA - Semnur Pharmaceuticals and Denali Capital Acquisition enter into a letter of intent for proposed business combination
2024-07-02 17:33:12 ET
More on Denali Capital Acquisition, Scilex Holding Company, etc.
- Scilex says total product net sales for June grew in the range of 77% to 116%
- Scilex gains FDA approval for liquid version of colchine for gout flares
- Financial information for Denali Capital Acquisition Corp.
- Seeking Alpha’s Quant Rating on Scilex Holding Company